Five new black box warnings are being added to the safety labels of extended-release and long-acting opioid painkillers, warning that the drugs are addictive, can cause life-threatening problems, and are easily abused and misused, the Food and Drug Administration (FDA) announced. Opioids are a potent class of painkillers that also give patients a feeling of euphoria, making them choice recreational drugs. The following brand-name drugs and their generic counterparts have updated labels reflecting the new warnings: Avinza (morphine sulfate) Extended-Release Capsules, Butrans (buprenorphine) Transdermal System, Dolophine (methadone hydrochloride) Tablets, Duragesic (fentanyl transdermal system), Embeda (morphine sulfate and naltrexone hydrochloride) Extended-Release ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.